Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
   Oragenics Highlights Encouraging Toxicology Data From Intranasal COVID Vaccine Candidate
   
  December 22, 2022
  Tickers 
   OGEN
  
  
  From Benzinga
 
   FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
   
  
  
  December 22, 2022
  From Benzinga
 
   Moderna Finalizes 10-Year Agreement With UK Government For mRNA Vaccine Manufacturing Centre
   
  December 22, 2022
  Tickers 
   MRNA
  
  
  From Benzinga
 
   FDA Authorizes Pfizer/BioNTech And Moderna's Bivalent COVID Shots For 6 Months Old
   
  
  
  December 08, 2022
  From Benzinga
 
   US Supports Delay On COVID Patent Waiver Extension Decision
   
  
  
  December 06, 2022
  From Benzinga
 
   After Famed COVID-19 Pill, Pfizer Inks Research Pact For Another Antiviral Candidate
   
  December 06, 2022
  Tickers 
   PFE
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
   
  November 30, 2022
  Tickers 
   DVAX
  
  
  From Benzinga
 From Benzinga
 
   Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults
   
  November 18, 2022
  Tickers 
   NVAX
  
  
  From Benzinga
 
   Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages
   
  
  
  November 18, 2022
  From Benzinga
 
   Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
   
  
  
  November 16, 2022
  From Benzinga
 
   Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
   
  
  
  November 15, 2022
  From Benzinga
 
   Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
   
  November 14, 2022
  Tickers 
   MRNA
  
  
  From Benzinga
 
   Relief Therapeutics, NRx Pharma Settle Litigation Regarding COVID-19 Treatment Candidate
   
  
  
  November 14, 2022
  From Benzinga
 
   Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
   
  
  
  November 11, 2022
  From Benzinga
 
   Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
   
  
  
  November 10, 2022
  From Benzinga
 
   Novavax Posts Unexpected Q3 Loss, But Revenue Surpass Expectations
   
  November 09, 2022
  Tickers 
   NVAX
  
  
  From Benzinga
 
   Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses
   
  November 08, 2022
  Tickers 
   NVAX
  
  
  From Benzinga
 
   Veru Shares Jump Over 40% Despite FDA Staff Raises Uncertainties Over Its COVID-19 Therapy
   
  November 07, 2022
  Tickers 
   VERU
  
  
  From Benzinga
 
   BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market
   
  
  
  November 04, 2022
  From Benzinga
 
   Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity
   
  
  
  November 04, 2022
  From Benzinga
 From Benzinga
 
   EXCLUSIVE: SAB Biotherapeutics Says Influenza, COVID-19 Candidates Showing Broad Efficacy Against Variants
   
  November 03, 2022
  Tickers 
   SABS
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
